Literature DB >> 21063013

Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates.

Michael Y Lin1, Bala Hota, Yosef M Khan, Keith F Woeltje, Tara B Borlawsky, Joshua A Doherty, Kurt B Stevenson, Robert A Weinstein, William E Trick.   

Abstract

CONTEXT: Central line-associated bloodstream infection (BSI) rates, determined by infection preventionists using the Centers for Disease Control and Prevention (CDC) surveillance definitions, are increasingly published to compare the quality of patient care delivered by hospitals. However, such comparisons are valid only if surveillance is performed consistently across institutions.
OBJECTIVE: To assess institutional variation in performance of traditional central line-associated BSI surveillance. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective cohort study of 20 intensive care units among 4 medical centers (2004-2007). Unit-specific central line-associated BSI rates were calculated for 12-month periods. Infection preventionists, blinded to study participation, performed routine prospective surveillance using CDC definitions. A computer algorithm reference standard was applied retrospectively using criteria that adapted the same CDC surveillance definitions. MAIN OUTCOME MEASURES: Correlation of central line-associated BSI rates as determined by infection preventionist vs the computer algorithm reference standard. Variation in performance was assessed by testing for institution-dependent heterogeneity in a linear regression model.
RESULTS: Forty-one unit-periods among 20 intensive care units were analyzed, representing 241,518 patient-days and 165,963 central line-days. The median infection preventionist and computer algorithm central line-associated BSI rates were 3.3 (interquartile range [IQR], 2.0-4.5) and 9.0 (IQR, 6.3-11.3) infections per 1000 central line-days, respectively. Overall correlation between computer algorithm and infection preventionist rates was weak (ρ = 0.34), and when stratified by medical center, point estimates for institution-specific correlations ranged widely: medical center A: 0.83; 95% confidence interval (CI), 0.05 to 0.98; P = .04; medical center B: 0.76; 95% CI, 0.32 to 0.93; P = .003; medical center C: 0.50, 95% CI, -0.11 to 0.83; P = .10; and medical center D: 0.10; 95% CI -0.53 to 0.66; P = .77. Regression modeling demonstrated significant heterogeneity among medical centers in the relationship between computer algorithm and expected infection preventionist rates (P < .001). The medical center that had the lowest rate by traditional surveillance (2.4 infections per 1000 central line-days) had the highest rate by computer algorithm (12.6 infections per 1000 central line-days).
CONCLUSIONS: Institutional variability of infection preventionist rates relative to a computer algorithm reference standard suggests that there is significant variation in the application of standard central line-associated BSI surveillance definitions across medical centers. Variation in central line-associated BSI surveillance practice may complicate interinstitutional comparisons of publicly reported central line-associated BSI rates.

Entities:  

Mesh:

Year:  2010        PMID: 21063013     DOI: 10.1001/jama.2010.1637

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

1.  Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.

Authors:  Matthew Kelly; Margaret Conway; Kathleen Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

Review 2.  Data elements and validation methods used for electronic surveillance of health care-associated infections: a systematic review.

Authors:  Kenrick D Cato; Bevin Cohen; Elaine Larson
Journal:  Am J Infect Control       Date:  2015-06       Impact factor: 2.918

3.  An electronic surveillance tool for catheter-associated urinary tract infection in intensive care units.

Authors:  Heather E Hsu; Erica S Shenoy; Douglas Kelbaugh; Winston Ware; Hang Lee; Pearl Zakroysky; David C Hooper; Rochelle P Walensky
Journal:  Am J Infect Control       Date:  2015-03-31       Impact factor: 2.918

4.  Electronic Surveillance For Catheter-Associated Urinary Tract Infection Using Natural Language Processing.

Authors:  Patrick C Sanger; Marion Granich; Robin Olsen-Scribner; Rupali Jain; William B Lober; Ann Stapleton; Paul S Pottinger
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

5.  What counts? An ethnographic study of infection data reported to a patient safety program.

Authors:  Mary Dixon-Woods; Myles Leslie; Julian Bion; Carolyn Tarrant
Journal:  Milbank Q       Date:  2012-09       Impact factor: 4.911

6.  Reducing central line infections in pediatric and neonatal patients.

Authors:  Simon Li; Edward Vincent S Faustino; Sergio G Golombek
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

7.  Zero risk for central line-associated bloodstream infections … Is this realistic?.

Authors:  Naomi P O'Grady
Journal:  Crit Care Med       Date:  2012-02       Impact factor: 7.598

8.  A national Infection in Critical Care Quality Improvement Programme for England: A survey of stakeholder priorities and preferences.

Authors: 
Journal:  J Intensive Care Soc       Date:  2016-02-01

9.  Public reporting of hospital-acquired infections is not associated with improved processes or outcomes.

Authors:  Darren R Linkin; Neil O Fishman; Judy A Shea; Wei Yang; Mark S Cary; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2013-06-25       Impact factor: 3.254

Review 10.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.